Cinaras Oral Liquid

Composition:
Each 100ml contains:
Enrofloxacin (Cinoxin)                                    7.5g
Sulphamethoxy Pyridazine                             7.5g
Sulphamethazine                                              5g
Trimethoprim                                                     2.5g
(As per Innovator’s Specifications)

Indications:

Cinaras Oral Liquid is used against diseases such as yolk sac infection, colibacillosis (E.coli spp), peritonitis, airsacculitis, synovitis and salpingitis. These diseases cause severe renal damage; hence Cinaras Oral Liquid is effective in these diseases.

Dosage and Administration:
Prevention:
1ml/2 liter of drinking water for 3 to 5 days.
Treatment:
1ml/1 liter of drinking water for continuously 3 to 5 days.